Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

NCT01612182 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT01612182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01612182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Lead sponsor
Inje University
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2012
Enrollment
1,289 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease